The global Vaccine Marketwas valued at USD 32.1 billion in 2016 and is projected to reach USD 59.01 billion by 2025, growing at a CAGR of 7% from 2017 to 2025.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism. The vaccine production market is seeing a rise because of prevalence of infections and flu diseases.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Cases of infections
1.2 Growing demand of immunization campaigns and programs
1.3 Growing focus on vaccine development and implementation
1.4 More funds for vaccine R&D in industries
2. Market Restraints
2.1 Product failure
2.2 High Cost of Vaccine development
Market Segmentation:
1. Global Vaccine Market, by Type:
1.1 Monovalent
1.2 Multivalent
2. Global Vaccine Market, by Technology:
2.1 Conjugate Vaccines
2.2 Inactivated and Subunit Vaccines
2.3 Live Attenuated Vaccines
2.4 Recombinant Vaccines
2.5 Toxoid Vaccines
3. Global Vaccine Market, by path ofAdministration:
3.1 Intramuscular and Subcutaneous Administration
3.2 Oral Administration
3.3 Other Routes of Administration
4. Global Vaccine Market, by Disease Indication:
4.1 Pneumococcal Disease
4.2 DTP
4.3 Influenza
4.4 Human Papilloma Virus
4.5 Meningococcal Disease
4.6 Polio
4.7 Rotavirus
4.8 Hepatitis
4.9 MMR
4.10 Varicella
4.11 Dengue
4.12 Other Disease Indications
5. Global Vaccine Market, by path ofEnd user:
5.1 Pediatrics
5.2 Adults
5.3 Veterinary Practices (Animals)
6. Global Vaccine Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Pfizer, Inc.
2. Glaxosmithkline PLC.
3. Merck & Co., Inc.
4. Sanofi Pasteur SA
5. CSL Limited
6. Emergent Biosolutions, Inc.
7. Johnson & Johnson
8. Medimmune, LLC (A Subsidiary of Astrazeneca)
9. AstellasPharma, Inc.
10. Serum Institute of India
11. Bavarian Nordic
12. Mitsubishi Tanabe Pharma Corporation
13. Daiichi Sankyo Company, Limited
14. Protein Sciences Corporation
15. Panacea Biotec
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Vaccine Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL VACCINE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL VACCINE MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL VACCINE MARKET, BY TYPE
5.1 Overview
5.2 Monovalent
5.3 Multivalent
6 GLOBAL VACCINE MARKET, BY TECHNOLOGY
6.1 Overview
6.2 Conjugate Vaccines
6.3 Inactivated and Subunit Vaccines
6.4 Live Attenuated Vaccines
6.5 Recombinant Vaccines
6.6 Toxoid Vaccines
7 GLOBAL VACCINE MARKET, BY PATH OF ADMINISTRATION
7.1 Overview
7.2 Intramuscular and Subcutaneous Administration
7.3 Oral Administration
7.4 Others
8 GLOBAL VACCINE MARKET, BY DISEASE INDICATION
8.1 Overview
8.2 Pneumococcal Disease
8.3 DTP
8.4 Influenza
8.5 Human Papilloma Virus
8.6 Meningococcal Disease
8.7 Polio
8.8 Rotavirus
8.9 Hepatitis
8.10 MMR
8.11 Varicella
8.12 Dengue
8.13 Others
9 GLOBAL VACCINE MARKET, BY PATH OF END USER
9.1 Overview
9.2 Pediatrics
9.3 Adults
9.4 Veterinary Practices (Animals)
10 GLOBAL VACCINE MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
11 GLOBAL VACCINE MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Pfizer, Inc.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Glaxosmithkline PLC.
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Sanofi Pasteur SA
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 CSL Limited
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Emergent Biosolutions, Inc.
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 Johnson & Johnson
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Medimmune, LLC
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 AstellasPharma, Inc.
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 Bavarian Nordic
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
12.11 Mitsubishi Tanabe Pharma Corporation
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments
12.12 Daiichi Sankyo Company, Limited
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments
12.13 Protein Sciences Corporation
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments
12.14 Panacea Biotec
12.14.1 Overview
12.14.2 Financial Performance
12.14.3 Product Outlook
12.14.4 Key Developments
12.15 Serum Institute of India
12.15.1 Overview
12.15.2 Financial Performance
12.15.3 Product Outlook
12.15.4 Key Developments
13 Appendix
13.1 Related Reports
The mRNA Vaccine Drugs Development Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Human Rabies Vaccine Antibody Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...
The Smart Vaccine Scenario-based Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Pet Rabies Vaccine Antibody Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Rabies Vaccine Antibody Testing Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Liquid Vaccine Filling Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Pharmaceutical Vaccine Refrigerators Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The White Oil for Vaccine Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
Executive Summary
Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...
Overview of the Global Vaccine Supply Chain Solutions Market:
The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...